Last updated on November 2019

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus


Brief description of study

The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).

Clinical Study Identifier: NCT03616964

Find a site near you

Start Over